TGFB1 and Crouzon syndrome-acanthosis nigricans syndrome: In conclusion, long term TSP-2 gene therapy did not ameliorate but unexpectedly rather worsened the progression of CAN in the Fischer-Lewis rat model despite the in vivo proof of TSP-2 and its ability to block both TSP-1 mediated TGF-β activation and cellular inflammation.